Primary surfactant deficiency in premature infants causes respiratory distress syndrome in premature infants. Surfactant injection technique to treat respiratory failure is currently being performed independently at Vinmec Hai Phong and Nha Trang since April 2019.

Neonatal respiratory distress syndrome, also known as hyaline membrane disease, is the most common condition in premature babies. The disease can leave many dangerous complications for the baby later on, even more dangerous is taking the baby's life if not detected and treated early.

Respiratory distress syndrome is common in premature infants, the younger the baby is, the higher the risk of respiratory failure. This is a very dangerous symptom for the baby's life, so it needs to be diagnosed early and intervened promptly.

Primary surfactant deficiency in premature infants causes respiratory distress syndrome. This syndrome is usually treated with surfactant supplementation. Previously, medicine often used the technique of infusing surfactant through the endotracheal tube and putting the baby on a ventilator. Today, the technique of infusing surfactant to treat neonatal respiratory distress is less invasive and is increasingly widely used.

Respiratory failure is a common syndrome in premature babies due to the respiratory system's inability to maintain gas exchange in accordance with the body's needs. The number of deaths due to respiratory failure is currently the leading cause of neonatal deaths.

Respiratory distress syndrome in newborns is common in premature babies, causing respiratory failure due to underdeveloped lungs and lack of surfactant, leading to reduced alveolar surface area for gas exchange.

Acute respiratory distress syndrome is common in premature infants, the younger the baby is, the higher the risk. This is a very dangerous syndrome for the baby's life, so it needs to be diagnosed and intervened promptly. So how to identify acute respiratory distress in newborns?

Neonatal respiratory failure is a respiratory dysfunction that leads to hypoxia and increased CO2 in the blood. This is the leading cause of death in newborns. Treatment of acute respiratory failure in newborns must be performed quickly to prevent respiratory failure, acidosis, infection, exhaustion, along with treatment of the cause.

Acute respiratory failure in newborns is one of the leading causes of death in newborns. Acute respiratory failure is often associated with diseases of the lungs and respiratory system.

Neonatal respiratory failure is most common in premature infants. The cause is that the baby's lungs are not yet fully developed, the alveolar surface area for gas exchange is not enough, causing respiratory failure. If not detected and treated promptly, it can lead to death in children.

Hyaline membrane disease in newborns is one of the common causes of acute respiratory failure, often occurring in premature infants. Hyaline membrane disease is caused by incomplete development of the respiratory tract and a lack of surfactant, an active substance on the inner surface of the alveoli.